Obesity and kidney disease: hidden consequences of the epidemic

CP Kovesdy, S Furth, C Zoccali… - Physiology …, 2017 - akjournals.com
Obesity has become a worldwide epidemic, and its prevalence has been projected to grow
by 40% in the next decade. This increasing prevalence has implications for the risk of …

Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease

W Herrington, B Lacey, P Sherliker, J Armitage… - Circulation …, 2016 - Am Heart Assoc
Atherosclerosis is a leading cause of vascular disease worldwide. Its major clinical
manifestations include ischemic heart disease, ischemic stroke, and peripheral arterial …

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

American Diabetes Association - Diabetes care, 2020 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models

DS Ludwig, CM Apovian, LJ Aronne, A Astrup… - European journal of …, 2022 - nature.com
The obesity pandemic continues unabated despite a persistent public health campaign to
decrease energy intake (“eat less”) and increase energy expenditure (“move more”). One …

Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus–mechanisms …

CC Low Wang, CN Hess, WR Hiatt, AB Goldfine - Circulation, 2016 - Am Heart Assoc
Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …

Healthy weight loss maintenance with exercise, liraglutide, or both combined

JR Lundgren, C Janus, SBK Jensen… - … England Journal of …, 2021 - Mass Medical Soc
Background Weight regain after weight loss is a major problem in the treatment of persons
with obesity. Methods In a randomized, head-to-head, placebo-controlled trial, we enrolled …

Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over

DH Ryan, SR Yockey - Current obesity reports, 2017 - Springer
Abstract Purpose of Review One begins to see improvement in glycemic measures and
triglycerides with small amounts of weight loss, but with greater levels of weight loss there is …

Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials

Y Lytvyn, P Bjornstad, JA Udell, JA Lovshin… - Circulation, 2017 - Am Heart Assoc
Despite current established therapy, heart failure (HF) remains a leading cause of
hospitalization and mortality worldwide. Novel therapeutic targets are therefore needed to …

American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …

WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Epidemiology of obesity and diabetes and their cardiovascular complications

SN Bhupathiraju, FB Hu - Circulation research, 2016 - Am Heart Assoc
Obesity and diabetes mellitus have reached epidemic proportions in the past few years.
During 2011 to 2012, more than one-third of the US population was obese. Although recent …